OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,077,000 | -33.1% | 394,436 | -39.4% | 0.00% | -40.0% |
Q1 2018 | $4,600,000 | -19.4% | 650,656 | +12.6% | 0.01% | -16.7% |
Q4 2017 | $5,705,000 | -2.6% | 578,005 | -13.4% | 0.01% | 0.0% |
Q3 2017 | $5,858,000 | -13.1% | 667,466 | +2.7% | 0.01% | -14.3% |
Q2 2017 | $6,739,000 | – | 650,074 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |